Novo Nordisk said its experimental next-generation obesity drug CagriSema helped patients cut their weight by 22.7% in a late-stage trial, below the 25% it had expected, wiping as much as $125 billion off its market value.
#News #novonordisk #wegovyweightloss #ozempic #Reuters #Newsfeed
Read the story here:
👉 Subscribe:
Keep up with the latest news from around the world: Follow Reuters on Facebook: Follow Reuters on Twitter: Follow Reuters on Instagram: #loss weight gummies #alli weight loss pill
Novo Nordisk plunges after obesity drug trial disappoints | REUTERS [6KcgsYPkddS]
Novo Nordisk said its experimental next-generation obesity drug CagriSema helped patients cut their weight by 22.7% in a late-stage trial, below the 25% it had expected, wiping as much as $125 billion off its market value.
#News #novonordisk #wegovyweightloss #ozempic #Reuters #Newsfeed
Read the story here:
👉 Subscribe:
Keep up with the latest news from around the world: Follow Reuters on Facebook: Follow Reuters on Twitter: Follow Reuters on Instagram: #loss weight gummies #alli weight loss pill